21 Dec, 2024
  • Submit Manuscript
Skip to content
  • Home
  • About Us
  • Open Access
  • Journals
  • Guidelines
    • For Editors
      • Editor Guidelines
      • Join as Editor
    • For Associate Editors
      • Associate Editor Guidelines
      • Join as Associate Editor
    • For Reviewers
      • Reviewer Guidelines
      • Join as Reviewer
    • For Authors
      • Author Guidelines
      • Peer Review Process
      • Plagiarism Policy
      • Processing Fee
    • Manuscript Guidelines
  • Submit Manuscript
  • Contact Us
Skeena Publishers | Open Access Journals
  • Home
  • About Us
  • Open Access
  • Journals
  • Guidelines
    • For Editors
      • Editor Guidelines
      • Join as Editor
    • For Associate Editors
      • Associate Editor Guidelines
      • Join as Associate Editor
    • For Reviewers
      • Reviewer Guidelines
      • Join as Reviewer
    • For Authors
      • Author Guidelines
      • Peer Review Process
      • Plagiarism Policy
      • Processing Fee
    • Manuscript Guidelines
  • Submit Manuscript
  • Contact Us
  • Home
  • Journals
  • International Journal on Oncology and Radiotherapy (IJOR)
  • Volume 2- Issue 2

Volume 2- Issue 2

Research Article

The Role of Radiotherapy in Relapse/Refractory Diffuse Large B-Cell Lymphoma in the Rituximab Era: A Systematic Review and Meta-Analysis

Farasat Kazmi*, Boon Fei Tan, Iris Huili Sin, Sharon Shuxian Poh, Balamurugan Vellayappan, Stephen Booth, Kheng-Wei Yeoh

ISSN: 2770-0054

IJOR Menu

  • Areas Focused
  • Archive
  • Articles In Press
  • Current Issue
  • Editorial Board

About Skeena Publishers

  • About Us
  • Open Access
  • Journals
  • FAQs
  • Terms & Conditions
  • Policies

Join Us

  • Join as Editor
  • Join as Associate Editor
  • Join as Reviewer
  • Submit Manuscript

For Authors

  • Author Guidelines
  • Editor Guidelines
  • Reviewer Guidelines
  • Manuscript Guidelines
  • Peer Review Process
  • Processing Fee

Contact Us:

2820 S Alma School Rd
Ste 18 – 608
Chandler AZ 85286

Phone : +1 (480) 374-3676‬

Email: [email protected]

Copyright © All rights reserved.